With the continuously rising cost of prescription drugs, patients are forced to take matters into their own hands. They are making choices that their doctors would advise against, and their health is suffering because of it. Dr. Sameer Awsare, an internist and...
The treatment of choice for rheumatic diseases has traditionally been the use of biological agents called bio-originators. These agents are derived from microorganisms, animals or humans. The increasing cost of these agents has put effective treatment out of the reach...
On June 29, the U.S. House of Representatives passed the Fiscal Year 2018 Department of Defense (DoD) Appropriations bill, which funds the country’s military and medical activities. Within that legislation, $5 million in funding was allocated to the Lupus Research...
In the wake of the much-publicized drug price hikes of common prescriptions such as Mylan’s Epipen and Turing’s Daraprim, patients and doctors alike have been scratching their heads about why drug prices keep increasing. Some reasons may be the rise of the cost of...
In 2017, refinements and improvements for the treatment of rheumatoid arthritis were extended to other ailments as well. This included findings for lupus, psoriatic arthritis, and more. Studies and tests have been done in the attempt to advance biologics, which are...
